CDMO Capacity Crunch ft. Discovery Labs' Audrey Greenberg And Iovance Biotherapeutics' Sumit Verma
HTML-код
- Опубликовано: 7 фев 2025
- While nary a day goes by without a shovel breaking ground on a new CDMO buildout, biopharmas remain hard-pressed to secure the outsourced manufacturing space and expertise needed to meet timelines, satisfy investors, and drive competitive advantage. On this episode of the Business of Biotech, we're tackling the CDMO capacity crunch from every angle in a spirited discussion with Discovery Labs & Center for Breakthrough Medicines Co-Founder Audrey Greenberg, Iovance SVP of Commercial Manufacturing Sumit Verma, and Project Farma CEO Anshul Mangal.
#businessofbiotech #biopharma #biotech #cytiva
cytiva.com/emer...
Audio version available here: www.bioprocess...
Subscribe to the podcast:
Apple - podcasts.apple...
Spotify - open.spotify.c...
Google - podcasts.googl...